Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney Injury
Background: Vancomycin is commonly used as a first line therapy for gram positive organisms such as methicillin resistant <i>Staphylococcus</i><i>aureus</i>. Vancomycin-induced acute kidney injury (V-AKI) has been reported in up to 43% of patients, especially in those with hi...
Main Authors: | Linda Awdishu, Amy Le, Jordan Amato, Vidhyut Jani, Soma Bal, Robert H. Mills, Marvic Carrillo-Terrazas, David J. Gonzalez, Ashita Tolwani, Anjali Acharya, Jorge Cerda, Melanie S. Joy, Paola Nicoletti, Etienne Macedo, Sucheta Vaingankar, Ravindra Mehta, Satish P. RamachandraRao, on behalf of the Direct Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/2784 |
Similar Items
-
Effect of First Trough Vancomycin Concentration on the Occurrence of AKI in Critically Ill Patients: A Retrospective Study of the MIMIC-IV Database
by: Li, L., et al.
Published: (2022) -
Laboratory correlation between vancomycin levels and serum creatinine in the nephrotoxicity of vancomycin
by: Luiza K.R.P. Araújo, et al.
Published: (2016-12-01) -
The Effect of Vitamin C in Preventing Vancomycin-Induced Nephrotoxicity; A Randomized Clinical Trial Study
by: Mohamadreza Yazdani, et al.
Published: (2019-12-01) -
Rationale and Design of the Genetic Contribution to Drug Induced Renal Injury (DIRECT) Study
by: Linda Awdishu, et al.
Published: (2016-11-01) -
Vancomycin Revisited - 60 years later
by: Ethan eRubinstein, et al.
Published: (2014-10-01)